300
Participants
Start Date
January 27, 2025
Primary Completion Date
April 30, 2029
Study Completion Date
April 30, 2030
SHIFT Intervention Group
Participants assigned to SHIFT will meet with their HCT clinician for a brief medical examination to assess the need for medications for erectile dysfunction, vaginal atrophy, or genital graft-versus-host disease; and start using SHIFT at their desired pace over 8 weeks to complete five modules.
Enhanced Usual Care Group
Participants assigned to the enhanced usual care group will meet with their HCT clinician for a brief medical examination to assess the need for medications for erectile dysfunction, vaginal atrophy, or genital graft-versus-host disease; and maybe referred to a psychologist, urologist, or gynecologist at the participants' request or at the discretion of the HCT clinician.
NOT_YET_RECRUITING
Fox Chase Cancer Center, Philadelphia
NOT_YET_RECRUITING
University of Miami, Coral Gables
RECRUITING
Massachusetts General Hospital (MGH), Boston
National Cancer Institute (NCI)
NIH
Massachusetts General Hospital
OTHER